SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Block listing update

8 Oct 2019 10:00

RNS Number : 1338P
Porvair PLC
08 October 2019
 

8 October 2019

 

Porvair plc

("Porvair" or the "Group")

 

Block listing update

 

Porvair, the specialist filtration and environmental technologies group, announces that an application has been made to the Financial Conduct Authority ("FCA") and London Stock Exchange ("LSE") in order to increase an existing block listing of ordinary shares of 2 pence per share ("Ordinary Shares") used to satisfy the issue of shares pursuant to exercises of options under the Porvair plc SAYE Share Option Plan 2014 ("SAYE Plan").

 

Application has been made for the admission of 510,269 new Ordinary Shares to the premium listing segment of the Official List of the FCA and to trading on the main market of the LSE (together "Admission"). New Ordinary Shares issued under the block listing will rank pari passu in all respect with the existing Ordinary Shares of the Company. It is expected that Admission will become effective on 10 October 2019.

 

In addition, the Company currently has 21,925 new Ordinary Shares admitted (but not yet issued) under an existing block listing that relate to the Porvair Long Term Share Plan 2008 (the "LTSP"). All share issues expected to be required in order to satisfy the exercise of options under the LTSP have been made and, as a result, the associated LTSP block listing will be cancelled. The Company made 151,375 allotments under the LTSP since the last block listing return. The block listing return, as at 7 October 2019 is set out below.

 

The Company's issued share capital will not change as a result of the changes to the block listings set out above.

 

Total Voting Rights

The Company's issued share capital consists of 45,843,599 Ordinary Shares with voting rights. Therefore, the total number of voting rights in the Company will be 45,843,599. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the disclosure guidance issued by the FCA and the transparency rules made by the FCA under section 89A(1) of the Financial Services and Markets Act 2000, as amended.

 

For more information, contact:

 

Porvair plc

 

Ben Stocks, Chief Executive

01553 765 500

Chris Tyler, Group Finance Director

01553 765 500

 

 

Buchanan

0207 466 5000

Charles Ryland / Stephanie Watson

 

 

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

 

Name of applicant:

Porvair plc

Name of scheme:

Porvair Long Term Share Plan 2008

Period of return:

From:

31 January 2018

To:

7 October 2019

Balance of unallotted securities under scheme(s) from previous return:

173,300

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(151,375)

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

21,925

 

Name of applicant:

Porvair plc

Name of scheme:

Porvair plc SAYE Share Option Plan 2014

Period of return:

From:

31 January 2018

To:

7 October 2019

Balance of unallotted securities under scheme(s) from previous return:

129,561

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

510,269

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(51,049)

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

588,781

 

 

Name of contact:

Chris Tyler (Group Finance Director)

Telephone number of contact:

01553 765 500

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSUWVWRKNARRRA
Date   Source Headline
1st Mar 20239:30 amRNSTotal Voting Rights
2nd Feb 20235:42 pmRNSGrant of LTSP awards
30th Jan 20237:00 amRNSResults for the year ended 30 November 2022
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSTrading Update, Notice of Results and Board Change
1st Dec 20224:00 pmRNSDirector/PDMR Shareholding
1st Dec 202210:00 amRNSTotal Voting Rights
29th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20224:00 pmRNSBlock listing Interim Review
1st Nov 20227:00 amRNSTotal Voting Rights
27th Oct 20229:30 amRNSDirector declaration and resignation
12th Oct 20224:26 pmRNSDirector/PDMR Shareholding
5th Oct 20225:30 pmRNSHolding(s) in Company
5th Oct 20225:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSTrading Update-Ahead of Expectations
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20224:41 pmRNSSecond Price Monitoring Extn
20th Sep 20224:36 pmRNSPrice Monitoring Extension
13th Sep 20227:00 amRNSNine Month Trading Update
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:35 pmRNSPrice Monitoring Extension
7th Sep 20226:05 pmRNSDirector/PDMR Shareholding
6th Sep 20224:40 pmRNSHolding(s) in Company
2nd Sep 20223:06 pmRNSHolding(s) in Company
10th Aug 20224:40 pmRNSSecond Price Monitoring Extn
10th Aug 20224:36 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSDirector Declaration
5th Jul 20224:35 pmRNSPrice Monitoring Extension
4th Jul 20227:00 amRNSHalf Year Results 2022
30th Jun 20222:15 pmRNSDirector/PDMR Shareholding
29th Apr 20224:41 pmRNSSecond Price Monitoring Extn
29th Apr 20224:36 pmRNSPrice Monitoring Extension
28th Apr 20227:00 amRNSDirector/PDMR Shareholding
14th Apr 20221:42 pmRNSAGM resolutions
14th Apr 20227:00 amRNSAGM Trading Update
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSBlock listing Interim Review
28th Feb 20227:00 amRNSTotal Voting Rights
4th Feb 20223:00 pmRNSDirector/PDMR Shareholding
4th Feb 202212:20 pmRNSGrant of LTSP awards
3rd Feb 202211:27 amRNSDirector/PDMR Shareholding
31st Jan 20227:00 amRNSResults for the year ended 30 November 2021
14th Dec 202112:25 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.